Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.

AIDS (London, England) - 14 Feb 2003

Levy Yves, Durier Christine, Krzysiek Roman, Rabian Claire, Capitant Catherine, Lascaux Anne-Sophie, Michon Christophe, Oksenhendler Eric, Weiss Laurence, Gastaut Jean-Albert, Goujard Cécile, Rouzioux Christine, Maral Jean, Delfraissy Jean-François, Emilie Dominique, Aboulker Jean-Pierre

Abstract excerpt

BACKGROUND: Intermittent interleukin-2 (IL-2) therapy leads to a sustained increase of CD4 T cells in HIV-1-infected patients. METHODS: Symptom-free HIV-1-infected patients who were naive to all antiretroviral drugs (n = 68) and/or to protease inhibitors (n = 50) and had a CD4 cell count of 200-550 x 10(6) cells/l were randomly assigned to start lamivudine/stavudine/indinavir alone (controls) or combined from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Administration, Cutaneous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibody Formation

Share to Antiretroviral Therapy, Highly Active

Share to CD4 Lymphocyte Count

Share to CD4-Positive T-Lymphocytes

Share to Drug Therapy, Combination

Share to Interleukin-2

Source

Identifiers

PMID: 12556688
DOI: 10.1097/00002030-200302140-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.PMID 12556688Read ↗

Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).Semantic proximity Read ↗

Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.Semantic proximity Read ↗

Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.Semantic proximity Read ↗

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.Semantic proximity Read ↗

Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion.Semantic proximity Read ↗

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.Semantic proximity Read ↗

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.Semantic proximity Read ↗

Traditional Chinese Medicine TN-01 Reconstitutes T Cells in SIV–infected Rhesus MonkeysSemantic proximity Read ↗

Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.Semantic proximity Read ↗

Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia.Semantic proximity Read ↗

Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.Semantic proximity Read ↗

A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.